日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Ixazomib, Lenalidomide, and Dexamethasone (IRD) Treatment with Cytogenetic Risk-Based Maintenance in Transplant-Eligible Myeloma: A Phase 2 Multicenter Study by the Nordic Myeloma Study Group

伊沙佐米、来那度胺和地塞米松（IRD）联合细胞遗传学风险维持治疗在适合移植的多发性骨髓瘤患者中的应用：北欧骨髓瘤研究组开展的一项II期多中心研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16051024
Partanen, Anu; Waage, Anders; Peceliunas, Valdas; Schjesvold, Fredrik; Anttila, Pekka; Säily, Marjaana; Uttervall, Katarina; Putkonen, Mervi; Carlson, Kristina; Haukas, Einar; Sankelo, Marja; Szatkowski, Damian; Hansson, Markus; Marttila, Anu; Svensson, Ronald; Axelsson, Per; Lauri, Birgitta; Mikkola, Maija; Karlsson, Conny; Abelsson, Johanna; Ahlstrand, Erik; Sikiö, Anu; Klimkowska, Monika; Matuzeviciene, Reda; Fenstad, Mona Hoysaeter; Ilveskero, Sorella; Pelliniemi, Tarja-Terttu; Nahi, Hareth; Silvennoinen, Raija
多发性骨髓瘤
细胞生物学
骨髓瘤
发表日期：2024
文献求助 收藏

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13

对于不适合移植的新诊断多发性骨髓瘤患者，采用伊沙佐米-沙利度胺-地塞米松诱导治疗，随后进行伊沙佐米或安慰剂维持治疗：HOVON-126/NMSG 21.13 研究的长期结果

期刊:Hemasphere
影响因子:14.6
doi:10.1097/HS9.0000000000000940
Groen, Kazimierz; Schjesvold, Fredrik H; van der Holt, Bronno; Levin, Mark-David; Seefat, Maarten R; Hansson, Markus; Leys, Maria B L; Regelink, Josien C; Waage, Anders; Szatkowski, Damian; Axelsson, Per; Hieu Do, Trung; Svirskaite, Asta; van der Spek, Ellen; Haukas, Einar; Knut-Bojanowska, Dorota; Ypma, Paula F; Blimark, Cecilie H; Mellqvist, Ulf-Henrik; van de Donk, Niels W C J; Sonneveld, Pieter; Klostergaard, Anja; Vangsted, Annette J; Abildgaard, Niels; Zweegman, Sonja
多发性骨髓瘤
多发性硬化症
骨髓瘤
发表日期：2023
文献求助 收藏

Longitudinal minimal residual disease assessment in multiple myeloma patients in complete remission - results from the NMSG flow-MRD substudy within the EMN02/HO95 MM trial

在完全缓解的多发性骨髓瘤患者中进行纵向微小残留病灶评估——EMN02/HO95 MM试验中NMSG flow-MRD子研究的结果

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09184-1
Schmitz, Alexander; Brøndum, Rasmus Froberg; Johnsen, Hans Erik; Mellqvist, Ulf-Henrik; Waage, Anders; Gimsing, Peter; Op Bruinink, Davine Hofste; van der Velden, Vincent; van der Holt, Bronno; Hansson, Markus; Andersen, Niels Frost; Frølund, Ulf Christian; Helleberg, Carsten; Schjesvold, Fredrik H; Ahlberg, Lucia; Gulbrandsen, Nina; Andreasson, Bjorn; Lauri, Birgitta; Haukas, Einar; Bødker, Julie Støve; Roug, Anne Stidsholt; Bøgsted, Martin; Severinsen, Marianne T; Gregersen, Henrik; Abildgaard, Niels; Sonneveld, Pieter; Dybkær, Karen
多发性骨髓瘤
多发性硬化症
骨髓瘤
发表日期：2022
文献求助 收藏

Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial

对于不适合自体干细胞移植的新诊断多发性骨髓瘤患者，采用伊沙佐米-沙利度胺-低剂量地塞米松诱导治疗，随后进行伊沙佐米或安慰剂维持治疗；来自随机II期HOVON-126/NMSG 21.13试验的结果

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2019.240374
Zweegman, Sonja; Stege, Claudia A M; Haukas, Einar; Schjesvold, Fredrik H; Levin, Mark-David; Waage, Anders; Leys, Rineke B L; Klein, Saskia K; Szatkowski, Damian; Axelsson, Per; Hieu Do, Trung; Knut-Bojanowska, Dorota; van der Spek, Ellen; Svirskaite, Asta; Klostergaard, Anja; Salomo, Morten; Blimark, Celine; Ypma, Paula F; Mellqvist, Ulf-Henrik; Poddighe, Pino J; Stevens-Kroef, Marian; van de Donk, Niels W C J; Sonneveld, Pieter; Hansson, Markus; van der Holt, Bronno; Abildgaard, Niels
发育与干细胞
干细胞
多发性骨髓瘤
多发性硬化症
骨髓瘤
细胞生物学
发表日期：2020
文献求助 收藏

Porous membrane substrates offer better niches to enhance the Wnt signaling and promote human embryonic stem cell growth and differentiation

多孔膜基质能够提供更佳的微环境，从而增强Wnt信号通路，促进人类胚胎干细胞的生长和分化。

期刊:Tissue Engineering Part A
影响因子:2.9
doi:10.1089/ten.TEA.2011.0474
Jin, Sha; Yao, Huantong; Krisanarungson, Pantrika; Haukas, Andreas; Ye, Kaiming
发育与干细胞
信号转导
Wnt/β-Catenin
干细胞
细胞生物学
发表日期：2012
文献求助 收藏